Combat Trauma Research Group, Department of Emergency Medicine, Naval Medical Center Portsmouth, Portsmouth, Virginia.
Department of Military and Emergency Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland.
Prehosp Emerg Care. 2024;28(5):680-688. doi: 10.1080/10903127.2024.2342025. Epub 2024 May 21.
Hemorrhage is the leading cause of preventable death in civilian trauma centers and on the battlefield. One of the emerging treatment options for hemorrhage in austere environments is tranexamic acid (TXA). However, the landscape is not amenable to the current delivery standard. This study compared the pharmacokinetics of TXA a standard 10-minute intravenous infusion (IV infusion), intravenous rapid push over 10 s (IV push), and intramuscular injection (IM) in a swine polytrauma and hemorrhagic shock model (trauma group) compared to uninjured controls (control group).
Thirty swine were randomized to the trauma or control group. Following anesthesia, the trauma group experienced a simulated blast injury and 40% controlled hemorrhage. Subjects in both groups were then randomized to receive 1 g/10 mL TXA IV infusion, IV push, or IM. Animals were monitored for four hours with serial blood sampling. Serum TXA concentrations were measured by liquid chromatography with tandem mass spectrometry (LC-MS/MS) and analyzed.
The time to maximum TXA concentration (T) was not affected by trauma in IV infusion or IV push, but was affected in the IM administration with T significantly slower than the control group ( = 0.016). The minimum effective serum concentration of TXA (C, 10 µg/mL) was reached in less than one minute with IV infusion and instantaneously with IV push. Despite lower bioavailability, the time to reach C (T) was achieved IM administration in less than 10 min for both groups (6.4 min trauma vs. 2.1 min control).
In austere prehospital environments, an alternative to intravenous infusion of a life-saving medication is desired. Administration of TXA all three methods reached the level needed to cause substantial inhibition of fibrinolysis within 10 min. The IV push method showed similar pharmacokinetics to IV infusion of TXA but can be delivered quickly without sacrificing an access site for 10 min.
出血是民用创伤中心和战场上可预防死亡的主要原因。在恶劣环境下治疗出血的一种新兴治疗选择是氨甲环酸(TXA)。然而,这种方法并不适合目前的输送标准。本研究比较了 TXA 在猪创伤和失血性休克模型(创伤组)中的药代动力学,分别为标准的 10 分钟静脉输注(IV 输注)、静脉快速推注 10 秒(IV 推注)和肌肉注射(IM),与未受伤的对照组(对照组)进行比较。
30 头猪随机分为创伤组或对照组。麻醉后,创伤组经历模拟爆炸伤和 40%的控制性出血。两组均随机接受 1g/10mLTXA 静脉输注、IV 推注或 IM。动物在 4 小时内接受连续采血监测。采用液相色谱-串联质谱法(LC-MS/MS)测定血清 TXA 浓度并进行分析。
创伤对 TXA 的最大浓度(T)时间无影响,IV 输注或 IV 推注,但在 IM 给药时受影响,T 明显慢于对照组(=0.016)。TXA 的最小有效血清浓度(C,10μg/mL)在 IV 输注中不到 1 分钟达到,在 IV 推注中瞬间达到。尽管生物利用度较低,但在 10 分钟内,两组均达到 C(T)时间,IM 给药在不到 10 分钟内(创伤组 6.4 分钟,对照组 2.1 分钟)。
在恶劣的院前环境中,需要一种替代静脉输注救命药物的方法。三种方法中的 TXA 给药都在 10 分钟内达到了显著抑制纤维蛋白溶解所需的水平。IV 推注方法与 TXA 的 IV 输注具有相似的药代动力学,但可以在不牺牲 10 分钟内的一个接入点的情况下快速给药。